Medidata Solutions (MDSO) Receives Analyst Rating

Medidata Solutions (MDSO) : The consensus on Medidata Solutions (MDSO) based on 9 analyst recommendation on the company stock is 1.94, which is interpreted as a Buy recommendation. Zacks Investment Research has issued a rank of 3 which endorses a Hold on the stock. However, 4 brokers have a differing view as they consider the stock to be a Strong Buy at current levels. 2 analyst believes that the stock is a Buy, which can produce decent returns in the future. 2 experts consider that the stocks earnings and the quoted price is in harmony, hence, they give it a Hold rating. 1 analyst also believes that the downside risk to the stock is higher and suggests a Sell on Medidata Solutions (MDSO).

Medidata Solutions (MDSO) has been rated by 7 research analysts. Fundamentally, the highest shorterm price forecast for the stock is expected to reach $65 and the lowest price target forecast is $36. The average forecast of all the analysts is $54.14 and the expected standard deviation is $9.1.


Also, Brokerage firm Wells Fargo downgrades its rating on Medidata Solutions (NASDAQ:MDSO). The shares have been rated Market Perform. Previously, the analysts had a Outperform rating on the shares. The rating by the firm was issued on July 21, 2016.

Medidata Solutions (NASDAQ:MDSO): After opening at $54.17, the stock dipped to an intraday low of $53.8812 on Thursday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $56.23 and the buying power remained strong till the end. The stock closed at $55.76 for the day, a gain of 3.11% for the day session. The total traded volume was 486,248. The stocks close on the previous trading day was $54.08.

Medidata Solutions Inc. (Medidata) provides cloud-based solutions for life sciences. The Companys solutions are Medidata Rave, an electronic data capture (EDC) and clinical data management system (CDMS) solution; Medidata CTMS, a clinical trial management solution; Medidata Designer, a protocol design tool; Medidata Insights, which offer clinical business analytics and metrics; Medidata Balance, a randomization and trial supply management solution; Medidata Patient Cloud, an electronic patient-reported outcome (ePRO) application; Medidata Grants Manager, which develops and manages trial budgets; Medidata contract research organizations (CRO) Contractor, an analytics tool; Medidata SQM, a set of cloud-based site quality management dashboards; Medidata Coder, a medical coding and synonym management solution; Medidata Safety Gateway, which collects and transmits events and related data from the EDC system, and Medidata Targeted SDV, which implements risk-based monitoring strategies.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.